Chain Drug Review - FDA approves applications for two drugs made by GSK
Thursday, January 8th, 2009GlaxoSmithKline PLC has received two significant marketing approvals from the Food and Drug Administration. Requip has been cleared as a treatment for moderate-to-severe restless legs syndrome in adults. Boostrix has been given the O.K. as the first combination vaccine to help protect adolescents against whooping cough.
Related Results
Requip for RLSRequip reduces risk of dyskine…
